LobbyingBridgebio Pharma lobbying by quarter
Bridgebio Pharma BBIO's latest lobbying report covers Q2 2026, at $560K. The four quarters Q4 2025–Q3 2026 total $1.4M. Its first report covers Q4 2023; the issues it reports most are Pharmacy and Health Issues.
Bridgebio PharmaBBIO
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $1.4M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2023 | $140K | 1 |
| Q1 2024 | $210K | 2 |
| Q2 2024 | $220K | 2 |
| Q3 2024 | $220K | 2 |
| Q4 2024 | $380K | 2 |
| Q1 2025 | $350K | 2 |
| Q2 2025 | $360K | 3 |
| Q3 2025 | $330K | 2 |
| Q4 2025 | $340K | 2 |
| Q1 2026 | $480K | 2 |
| Q2 2026 | $560K | 2 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$3.4M · 17 reports
- Health issues$115K · 5 reports
- Medicare and Medicaid$115K · 5 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES22 reports
- SENATE22 reports
- Food & Drug Administration (FDA)5 reports
- Centers For Medicare and Medicaid Services (CMS)4 reports
- Health & Human Services, Dept of (HHS)2 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseBridgebio Pharma | $3.1M | 11 quarters |
| Marshall & Popp | $260K | 5 quarters |
| Thorn Run Partners | $230K | 5 quarters |
| Todd Strategy Group | $20K | 1 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| HAZEN CLAY MARSHALL | Policy Director-Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles | Q2 2026 |
| MONICA POPP | Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint | Q2 2026 |
| SCOTT HINKLE | Sr. Leg. Assistant and Counsel, Policy Dir. and Counsel, Leg. Dir. and Counsel, Deputy Chief of Staff (CoS)/Leg. Dir./Counsel, CoS and Counsel, DC CoS and Counsel, Sr. Advisor and Counsel for Rep. Juan Vargas; CoS and Counsel for Rep. Raul Ruiz | Q2 2026 |
| TRIPP ADAMS | Staff Assistant and Legislative Correspondent for Sen. Johnny Isakson; Legislative Correspondent for Sen. Kelly Loeffler; Health Research Assistant and Staff Member for the Senate Health, Education, Labor and Pensions Committee. | Q1 2026 |
| DANIEL M TODD | Senior Health Counsel, Senate Finance Committee; Special Assistant, Office of Admin. Ct. - Medicare & Medicaid | Q2 2025 |
| KATHERINE FLEMING COTTON | Staff Assistant, Legislative Correspondent, Legislative Assistant - U.S. Representative Brett Guthrie | Q2 2025 |
| NICHOLAS UEHLECKE | Senior Advisor, Dept. of Health and Human Services; Professional Staff/Sr. Legislative Assistant, House Ways and Means Subcommittee | Q2 2025 |
| PAUL EDATTEL | Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg | Q2 2025 |
| BEAU SCHUYLER | Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre | Q1 2025 |
| JESSIE HOWE BRAIRTON | Senior Legislative Asst/Legislative Asst, Rep. Lamar Smith; LC/Asst, Senate Special Aging Committee | Q1 2025 |
| MICHAEL CALVO | Rep. Taylor (NC-11) Intern, Leg. Correspondent, Leg. Asst. Rep. McHenry (NC-10) Policy Advisor Rep. Gingrey (GA-11) Senior Leg. Asst., Senior Policy Advisor, Leg. Director, Deputy Chief of Staff Rep. Hice (GA-10) Leg. Director | Q4 2024 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $500K |
| 07/17for Q4 2025 | In-house | $280K |
| 07/17for Q4 2024 | In-house | $330K |
| 07/17for Q1 2024 | In-house | $160K |
| 07/17for Q4 2023 | In-house | $140K |
| 07/09for Q2 | Marshall & Popp | $60K |
| 04/20for Q1 | In-house | $420K |
| 04/17for Q1 | Marshall & Popp | $60K |
| 01/20for Q4 2025 | In-house | $270K |
| 01/16for Q4 2025 | Marshall & Popp | $60K |
| 25/10/20for Q3 2025 | In-house | $270K |
| 25/10/20for Q3 2025 | Marshall & Popp | $60K |
| 25/10/11for Q2 2025 | Todd Strategy Group | $20K |
| 25/07/30for Q2 2025 | Todd Strategy Group | $20K |
| 25/07/21for Q2 2025 | Todd Strategy Group | Under $5,000 |
| 25/07/21for Q2 2025 | Marshall & Popp | $20K |
| 25/07/17for Q2 2025 | In-house | $320K |
| 25/07/10for Q2 2025 | Marshall & Popp | Under $5,000 |
| 25/04/18for Q1 2025 | In-house | $320K |
| 25/03/13for Q1 2025 | Thorn Run Partners | $30K |